Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Activities:    
Net loss $ (5,904) $ (3,022)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization [note 3] 65 86
Stock-based compensation [note 6 [c] and note 6 [d]] 290 181
Cumulative adjustment on adoption of lease standard (3)  
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 88 217
Accounts payable 550 207
Accrued liabilities other (199) 94
Accrued clinical liabilities 887 (103)
Accrued compensation (680) 134
Other liabilities 17 (27)
Net cash used in operating activities (4,889) (2,233)
Financing Activities:    
Proceeds from purchase agreement with Lincoln Park Capital, net of issuance costs   1,105
Net cash provided by financing activities   1,105
Investing Activities:    
Purchase of property and equipment (54)  
Proceeds on disposal of assets   10
Purchase of investments (20)  
Proceeds from maturities of investments 2,764  
Net cash provided by investing activities 2,690 10
Effect of exchange rate changes on cash 4 (1)
Net increase (decrease) in cash, cash equivalents and restricted cash (2,195) (1,119)
Cash, cash equivalents and restricted cash at beginning of the period 9,565 5,556
Cash, cash equivalents and restricted cash at end of the period $ 7,370 $ 4,437